Zenith Capital Corp
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company's lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer in collaboration with Astellas and Newsoara, as well as advanced or meta… Read more
Zenith Capital Corp (ZHCLF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2024: 0.033x
Based on the latest financial reports, Zenith Capital Corp (ZHCLF) has a cash flow conversion efficiency ratio of 0.033x as of July 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-722.00) by net assets ($-21.71K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zenith Capital Corp - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Zenith Capital Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zenith Capital Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zenith Capital Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Macromill Embrain Co. Ltd
KQ:169330
|
-0.098x |
|
Induct AS
OL:INDCT
|
N/A |
|
Nuvotec
KQ:060260
|
-0.075x |
|
T T Limited
NSE:TTL
|
-0.057x |
|
Arrowhead Properties Ltd B
JSE:FTB
|
0.046x |
|
Rokiskio Suris AB
MU:YTV
|
0.002x |
|
INSIG AI PLC LS-01
F:8LF
|
N/A |
|
HYDROG.-REF.-SOL. EO-10
F:1FO
|
N/A |
Annual Cash Flow Conversion Efficiency for Zenith Capital Corp (2013–2024)
The table below shows the annual cash flow conversion efficiency of Zenith Capital Corp from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-04-30 | $-20.16K | $-4.91K | 0.244x | -54.75% |
| 2023-04-30 | $-14.86K | $-8.00K | 0.538x | +58.09% |
| 2022-04-30 | $-2.49K | $-847.00 | 0.341x | -90.57% |
| 2021-04-30 | $-2.19K | $-7.93K | 3.611x | +359.69% |
| 2020-04-30 | $-3.48K | $-2.73K | 0.786x | -46.20% |
| 2019-04-30 | $-3.77K | $-5.51K | 1.460x | +137.28% |
| 2018-04-30 | $2.25K | $-8.82K | -3.917x | -184.76% |
| 2017-04-30 | $9.97K | $-13.72K | -1.376x | -376.02% |
| 2016-04-30 | $-8.76K | $-4.36K | 0.498x | -70.33% |
| 2015-04-30 | $-5.34K | $-8.97K | 1.680x | -64.19% |
| 2014-04-30 | $-3.43K | $-16.07K | 4.691x | +784.82% |
| 2013-04-30 | $-18.19K | $-9.64K | 0.530x | -- |